HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

AVE 5026

a hemisynthetic ultra-low molecular weight analog for preventing venous thromboembolism
Also Known As:
AVE-5026; AVE5026
Networked: 3 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Walenga, Jeanine M: 1 article (09/2014)
2. Hoppensteadt, Debra A: 1 article (09/2014)
3. Fareed, Jawed: 1 article (09/2014)
4. Jeske, Walter P: 1 article (09/2014)
5. Gray, Angel: 1 article (09/2014)
6. Laux, V: 1 article (07/2009)
7. Lorenz, M: 1 article (07/2009)
8. Just, M: 1 article (07/2009)
9. Viskov, C: 1 article (07/2009)
10. Mourier, P: 1 article (07/2009)

Related Diseases

1. Thrombosis (Thrombus)
2. Venous Thrombosis (Deep-Vein Thrombosis)
3. Hemorrhage
4. Venous Thromboembolism
5. Thrombocytopenia (Thrombopenia)

Related Drugs and Biologics

1. Enoxaparin (Lovenox)
2. Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
3. Heparin (Liquaemin)
4. Antibodies

Related Therapies and Procedures

1. Knee Replacement Arthroplasty (Total Knee Replacement)